Xian F. Luo
No. 197, Ruijin 2nd Rd
Shanghai, 200025, China
Shanghai, 200025, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Safety of fruquintinib mono- and combo therapy in metastatic colorectal cancer: real-world subgroup analysis from China.
Journal: Future oncology (London, England)
Published: May 28, 2026
Safety of fruquintinib in Chinese patients with colorectal cancer: an age subgroup analysis from a phase IV real-world clinical practice study.
Journal: Therapeutic advances in medical oncology
Published: March 10, 2025
Surufatinib in advanced neuroendocrine tumours: Final overall survival from two randomised, double-blind, placebo-controlled phase 3 studies (SANET-ep and SANET-p).
Journal: European journal of cancer (Oxford, England : 1990)
Published: January 07, 2025
Sovleplenib in patients with primary or secondary warm autoimmune haemolytic anaemia: results from phase 2 of a randomised, double-blind, placebo-controlled, phase 2/3 study.
Journal: The Lancet. Haematology
Published: August 01, 2024
Baseline radiologic features as predictors of efficacy in patients with pancreatic neuroendocrine tumors with liver metastases receiving surufatinib.
Journal: Chinese journal of cancer research = Chung-kuo yen cheng yen chiu
Published: July 24, 2023
NBS-induced intramolecular annulation reactions for the divergent synthesis of fused- and spirocyclic indolines.
Journal: Chemical communications (Cambridge, England)
Published: May 15, 2023
Long-Term Efficacy, Safety, and Subgroup Analysis of Savolitinib in Chinese Patients With NSCLCs Harboring MET Exon 14 Skipping Alterations.
Journal: JTO clinical and research reports
Published: May 24, 2022
Circulating tumour DNA biomarkers in savolitinib-treated patients with non-small cell lung cancer harbouring MET exon 14 skipping alterations: a post hoc analysis of a pivotal phase 2 study.
Journal: Therapeutic advances in medical oncology
Published: April 05, 2022
Once-daily savolitinib in Chinese patients with pulmonary sarcomatoid carcinomas and other non-small-cell lung cancers harbouring MET exon 14 skipping alterations: a multicentre, single-arm, open-label, phase 2 study.
Journal: The Lancet. Respiratory medicine
Published: December 24, 2020
Relationship between glucagon-like peptide-1 receptor gene polymorphism and bone mineral density in postmenopausal women in Shanghai.
Journal: Annals of palliative medicine
Published: October 19, 2019
Pharmacokinetics of Single and Repeat Doses of Fluticasone Furoate/Umeclidinium/Vilanterol in Healthy Chinese Adults.
Journal: Clinical pharmacology in drug development
Published: June 22, 2018
Last Updated: 09/26/2026